Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Steroid Biochemistry

• Publication date

  1989-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-4731(89)90380-4PMID 2542691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Active nonaromatic intermediates in the conversion of steroidal estrogens into catechol estrogens.

  1986cited by this paper
• The characteristic binding of catechol estrogens to estrogen receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

  1986cited by this paper
• Catecholestrogen binding sites in breast cancer.

  1985cited by this paper
• Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.

  1984cited by this paper
• Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells.

  1984cited by this paper
• Metabolism of 2-methoxyestrone in normal men.

  1983cited by this paper
• Immunohistochemical localization of catechol methyltransferase in normal and cancerous breast tissues of mice and rats.

  1983cited by this paper
• Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity.

  1983cited by this paper
• Inhibition of phasic but not tonic pituitary secretion by 2-hydroxyoestrone in the rat: evidence of action as an oestrogen antagonist.

  1983cited by this paper
• Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.

  1983cited by this paper
• Relative rates of 2‐ and 4‐hydroxyestrogen synthesis are dependent on both substrate and tissue

  1982cited by this paper
• Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

  1982cited by this paper
• Comparative pharmacology of oestrogens and catechol oestrogens: actions on the immature rat uterus in vivo and in vitro.

  1982cited by this paper
• Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma.

  1981cited by this paper
• Methods of steroid receptor analyses and their quality control in the clinical laboratory.

  1981cited by this paper
• Central and peripheral action of estradiol and catecholestrogens administered at low concentration by constant infusion.

  1981cited by this paper
• Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.

  1981cited by this paper
• Actions of catechol oestrogens on concentrations of serum luteinizing hormone in the adult castrated rat: various effects of 4-hydroxyoestradiol and 2-hydroxyoestradiol.

  1981cited by this paper
• Interactions of Catecholestrogens with Cytoplasmic and Nuclear Estrogen Receptors in Rat Pituitary Gland and Hypothalamus

  1981cited by this paper
• The catechol estrogens.

  1981cited by this paper
• Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors.

  1980cited by this paper
• Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.

  1980cited by this paper
• Biomimetic synthesis of catechol estrogens: potentially mutagenic arene oxide intermediates in estrogen metabolism.

  1980cited by this paper
• Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.

  1980cited by this paper
• The enzymatic formation of catecholestrogens from 2-methoxyestrogens by rat liver microsomes.

  1980cited by this paper
• Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.

  1980cited by this paper
• Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion.

  1979cited by this paper
• Catecholestrogen synthesis and metabolism by human breast tumors in vitro.

  1979cited by this paper
• Mechanism of Fusarium mycotoxin action in mammary gland.

  1978cited by this paper
• Steroid hydroxylase induction in cultured human lymphocytes: effects of the menstrual cycle.

  1978cited by this paper
• Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol.

  1977cited by this paper
• Metabolism of 2-methoxy- and 4-methoxyoestrone in man in vivo.

  1977cited by this paper
• A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.

  1977cited by this paper
• A Novel, Two-Step Synthesis of 2-Methoxyestradiol

  1977cited by this paper
• Catechol-O-methyltransferase in human breast cancers.

  1977cited by this paper
• Mathematics of Hormone-Receptor Interaction

  1973cited by this paper
• Aromatic ring hydroxylation of estradiol in man.

  1970cited by this paper
• A simple ultraviolet spectrophotometric method for the determination of protein.

  1956cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• 4-Hydroxyestrogen Metabolites Strongly Prevent Chemically-Induced Ferroptotic Hepatocyte Injury In Vitro and In Vivo.

  2025cites this paper
• Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes

  2024cites this paper
• Comparison of Estrogenic Components Used for Hormonal Contraception.

  2023cites this paper
• Pharmacological inhibition of mitochondrial soluble adenylyl cyclase in astrocytes causes activation of AMP‐activated protein kinase and induces breakdown of glycogen

  2021cites this paper
• Endogenous estrogens—breast cancer and chemoprevention

  2021cites this paper
• The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support: Running title: 2-/16α-Hydroxyestrone-Breast Cancer Risk Hypothesis.

  2020cites this paper
• The Multifarious Link between Cytochrome P450s and Cancer

  2020cites this paper
• Markers of Local and Systemic Estrogen Metabolism in Endometriosis

  2020cites this paper
• Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone.

  2019cites this paper
• Adenomyosis: genetics of estrogen metabolism

  2019cites this paper
• Depression enhanced the production of autoantibodies against 16&agr;‐hydroxyestrone‐estrogen receptor adduct in breast cancer

  2019cites this paper
• Lack of Cell Proliferative and Tumorigenic Effects of 4-Hydroxyestradiol in the Anterior Pituitary of Rats: Role of Ultrarapid O-Methylation Catalyzed by Pituitary Membrane-Bound Catechol-O-Methyltransferase.

  2017cites this paper
• The Bone Sparing Effects of 2-Methoxyestradiol Are Mediated via Estrogen Receptor- (cid:2) in Male Mice

  2016cites this paper
• Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes

  2016cites this paper
• The Bone Sparing Effects of 2-Methoxyestradiol Are Mediated via Estrogen Receptor-α in Male Mice

  2016cites this paper
• Estrogen metabolism and breast cancer.

  2015cites this paper
• Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.

  2015cites this paper
• Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.

  2014cites this paper
• Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission

  2014cites this paper
• In Vitro Assay Systems for the Assessment of Oestrogenicity

  2014cites this paper
• Breast cancer and flavonoids - a role in prevention.

  2013cites this paper
• Extra-hepatic isozymes from the CYP1 and CYP2 families as potential chemotherapeutic targets.

  2013cites this paper
• Association between Reproductive Factors and Urinary Estrogens and Estrogen Metabolites in Premenopausal Women

  2012cites this paper
• Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

  2012cites this paper
• A Single-Nucleotide Polymorphism in the Fetal Catechol-O-methyltransferase Gene is Associated With Spontaneous Preterm Birth in African Americans

  2012cites this paper
• In vitro effects of 2-hydroxyestradiol-17β on ovarian follicular steroid secretion in the catfish Heteropneustes fossilis and identification of the receptor and signaling mechanisms.

  2012cites this paper
• Estrogen sulfotransferase (sult1e1) expression and function in mcf10a-series breast epithelial cells: role as a modifier of breast carcinogenesis and regulation by proliferation state

  2011cites this paper
• Dual roles of estrogen metabolism in mammary carcinogenesis.

  2011cites this paper
• Genetic polymorphisms in sex hormone metabolizing genes and drug response in women with epilepsy.

  2010cites this paper
• [Estrogen intracrinology: therapy and chemoprevention of breast cancer].

  2010cites this paper
• Circulating Sex Steroids and Breast Cancer Risk in Premenopausal Women

  2010cites this paper
• Regulación de la maduración de ovocitos por factores paracrinos

  2010cites this paper
• Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

  2010influential citation
• Selective inhibition of methoxyflavonoids on human CYP1B1 activity.

  2010cites this paper
• Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women

  2009cites this paper
• Morphological effects of the catecholestrogens on cells of the seminiferous tubules of Sprague‐Dawley rats

  2009cites this paper
• Reproducibility of Fifteen Urinary Estrogens and Estrogen Metabolites over a 2- to 3-Year Period in Premenopausal Women

  2009cites this paper
• Role of xenobiotic metabolic enzymes in cancer epidemiology.

  2009cites this paper
• Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor of MCF-7 cells in cytosolic extracts and in nuclei of intact cells.

  2009cites this paper
• Circulating Estrogen Metabolites and Risk for Breast Cancer in Premenopausal Women

  2009cites this paper
• Circulating Estrogen Metabolites and Risk of Breast Cancer in Postmenopausal Women

  2009cites this paper
• The Role of 17beta-Estradiol on 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Oxidative DNA Damage in Liver Cell Models

  2009cites this paper
• Circulating 2-Hydroxy- and 16α-Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women

  2008cites this paper
• 2-Methoxyestradiol Mediates Apoptosis Through Caspase-Dependent and Independent Mechanisms in Ovarian Cancer Cells But Not in Normal Counterparts

  2008cites this paper
• Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.

  2008cites this paper
• Pathway to Elevate Cyclooxygenase 2 Expression and Prostaglandin E 2 Secretion in Human Bronchial Epithelial Cells

  2008cites this paper
• 17-Beta estradiol and hydroxyestradiols interact via the NF-kappa B pathway to elevate cyclooxygenase 2 expression and prostaglandin E2 secretion in human bronchial epithelial cells.

  2008cites this paper
• Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.

  2007cites this paper
• Absence of uterine tumours in CD-1 mice treated neonatally with subcutaneous tamoxifen or 4-hydroxyoestradiol.

  2007cites this paper
• Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

  2007cites this paper
• The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium.

  2007cites this paper
• Single nucleotide polymorphisms of CYP2C19 gene and AHR gene and their associations to colorectal cancer and breast cancer risk in Han Chinese population

  2007cites this paper
• Estrogen metabolism and breast cancer risk--a review.

  2006cites this paper
• A New Hypothesis for Uterine Carcinogenesis: A Pathway Driven by Modulation of Estrogen Metabolism through Cytochrome P450 Induction in the Rat Liver

  2006cites this paper
• Case–control study of risk factors for breast cancer in Nigerian women

  2006cites this paper
• Regioselective 2-hydroxylation of 17beta-estradiol by rat cytochrome P4501B1.

  2006cites this paper
• Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas

  2006cites this paper
• Role of Polymorphic Human Cytochrome P450 Enzymes in Estrone Oxidation

  2006cites this paper
• Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells.

  2005cites this paper
• Estrogens II: Catechol, Estrogens

  2005cites this paper
• Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues.

  2004cites this paper
• Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism.

  2004cites this paper
• Exposure of Bovine Oocytes to the Endogenous Metabolite 2-Methoxyestradiol During In Vitro Maturation Inhibits Early Embryonic Development1

  2003cites this paper
• Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments

  2003cites this paper
• Discovery of cytochrome P450 1B1 inhibitors as new promising anti‐cancer agents

  2003influential citation
• A Potential Role for the Estrogen-metabolizing Cytochrome P450 Enzymes in Human Breast Carcinogenesis

  2003cites this paper
• Genetic determinants of mammographic density

  2002cites this paper
• Electrochemical evaluation of the interaction between endocrine disrupter chemicals and estrogen receptor using 17,beta-estradiol labeled with daunomycin.

  2002cites this paper
• The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.

  2001cites this paper
• Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats.

  2001influential citation
• Estrogenic activity of estradiol and its metabolites in the ER‐CALUX assay with human T47D breast cells Note

  2001cites this paper
• Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?

  2001cites this paper
• Cellular and biochemical mechanisms by which environmental oestrogens influence reproductive function.

  2000cites this paper
• Incorporation of S-9 activation into an ER-α transactivation assay☆

  2000cites this paper
• Soy consumption alters endogenous estrogen metabolism in postmenopausal women.

  2000cites this paper
• Incorporation of S-9 activation into an ER-alpha transactivation assay.

  2000cites this paper
• Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.

  2000cites this paper
• Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

  1999cites this paper
• Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

  1999cites this paper
• Chemical modulation of activity in steroidal estrogens.

  1999cites this paper
• Menstrual cycle effects on urinary estrogen metabolites.

  1999cites this paper
• Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland.

  1999cites this paper
• Rapid screening of environmental chemicals for estrogen receptor binding capacity.

  1998cites this paper
• The ligand insertion hypothesis in the genomic action of steroid hormones.

  1998cites this paper
• Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women.

  1998cites this paper
• Estrogen receptor mutations.

  1998cites this paper
• Role of quinoids in estrogen carcinogenesis.

  1998cites this paper
• Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?

  1998cites this paper
• Functional role of estrogen metabolism in target cells: review and perspectives.

  1998cites this paper
• The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.

  1997cites this paper
• Molecular mechanisms of estrogen carcinogenesis.

  1996cites this paper
• Molecular Mechanisms of Estrogen Carcinogenesis

  1996cites this paper
• Skeletal conformations and receptor binding of some 9,11-modified estradiols.

  1994cites this paper
• Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells.

  1994cites this paper
• Catecholestrogens are MCF-7 cell estrogen receptor agonists.

  1993cites this paper
• Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells.

  1992cites this paper
• Methyl and bromo derivatives of estradiol are agonistic ligands for the estrogen receptor of MCF-7 breast cancer cells.

  1991cites this paper
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells.

  1990cites this paper
• Formation, metabolism, and physiologic importance of catecholestrogens.

  1990cites this paper
• Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates.

  1990cites this paper